Unit Code 88878:
Alpha-Fetoprotein (AFP) L3% and Total, Hepatocellular Carcinoma Tumor Marker, Serum
Useful For
Suggests clinical disorders or settings where the test may be helpful
Distinguishing between hepatocellular carcinoma and chronic liver
disease
Monitoring individuals with hepatic cirrhosis from any etiology for
progression to hepatocellular carcinoma
Surveillance for development of hepatocellular carcinoma in
individuals with a positive family history of hepatic cancer
Surveillance for development of hepatocellular carcinoma in
individuals within specific ethnic and gender groups who do not
have hepatic cirrhosis, but have a confirmed diagnosis of chronic
infection by hepatitis B acquired early in life including:
- African males above the age of 20
- Asian males above the age of 40
- Asian females above the age of 50
Method Name
A short description of the method used to perform the test
Immunoenzymatic/Liquid Phase Binding
Reporting Name
A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
AFP-L3% and Total AFP, S
Ordering Mnemonic
An alternate Mayo code (to the Unit Code) for a test
L3AFP
Aliases
Lists additional common names for a test, as an aid in searching
Soft-L3AFP


